Report Detail

Request for Sample of this report

Medical Devices & Consumables Global Alpha-Fetoprotein (AFP) Biomarker Market 2026 by Company, Regions, Type and Application, Forecast to 2032

  • RnM4680269
    • |
  • 26 February, 2026
    • |
  • Global
    • |
  • 101 Pages
    • |
  • GIR
    • |
  • Medical Devices & Consumables

According to our (Global Info Research) latest study, the global Alpha-Fetoprotein (AFP) Biomarker market size was valued at US$ million in 2025 and is forecast to a readjusted size of US$ million by 2032 with a CAGR of %during review period.
Hepatocellular carcinoma (HCC) is the seventh most common cancer diagnosis worldwide with high associated mortality. HCC is a unique malignancy, as it typically arises in the setting of chronic liver disease in particular cirrhosis, with competing risks of liver failure, contributing to its low 5-year survival rates of 18%–20%. More than half of worldwide HCC-related deaths occur in Asia, due to endemic hepatitis B (HBV) infection. HCC incidence is rising in many Western countries due to the rising prevalence of nonalcoholic fatty liver disease, alcohol-related liver disease, and hepatitis C (HCV)-related complications despite the availability of direct acting antiviral therapies. The search for biomarkers in hepatocellular carcinoma continues despite recent approvals for immune checkpoint inhibitor combinations, tyrosine kinase inhibitors [TKIs], and antiangiogenesic agents. Biomarkers can be either predictive or prognostic and the only biomarker that has been used clinically is the prognostic biomarker α-fetoprotein (AFP).
This report is a detailed and comprehensive analysis for global Alpha-Fetoprotein (AFP) Biomarker market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Alpha-Fetoprotein (AFP) Biomarker market size and forecasts, in consumption value ($ Million), 2021-2032
Global Alpha-Fetoprotein (AFP) Biomarker market size and forecasts by region and country, in consumption value ($ Million), 2021-2032
Global Alpha-Fetoprotein (AFP) Biomarker market size and forecasts, by Type and by Application, in consumption value ($ Million), 2021-2032
Global Alpha-Fetoprotein (AFP) Biomarker market shares of main players, in revenue ($ Million), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Alpha-Fetoprotein (AFP) Biomarker
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Alpha-Fetoprotein (AFP) Biomarker market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include FUJIFILM, Eli Lilly and Company, Fujirebio, Roche Diagnostics, Fapon Biotech, Labcorp, Thermo Fisher Scientific, Abcam, Bio-Techne, MyBiosource, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market segmentation
Alpha-Fetoprotein (AFP) Biomarker market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Liver Cancer
Testes Cancer
Ovarian Cancer
Others
Market segment by Application
Hospitals
Clinics
Others
Market segment by players, this report covers
FUJIFILM
Eli Lilly and Company
Fujirebio
Roche Diagnostics
Fapon Biotech
Labcorp
Thermo Fisher Scientific
Abcam
Bio-Techne
MyBiosource
RayBiotech
CUSABIO
Elabscience Biotechnology
Abbexa
Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Alpha-Fetoprotein (AFP) Biomarker product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Alpha-Fetoprotein (AFP) Biomarker, with revenue, gross margin, and global market share of Alpha-Fetoprotein (AFP) Biomarker from 2021 to 2026.
Chapter 3, the Alpha-Fetoprotein (AFP) Biomarker competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2021 to 2032.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2021 to 2026.and Alpha-Fetoprotein (AFP) Biomarker market forecast, by regions, by Type and by Application, with consumption value, from 2027 to 2032.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Alpha-Fetoprotein (AFP) Biomarker.
Chapter 13, to describe Alpha-Fetoprotein (AFP) Biomarker research findings and conclusion.


1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Classification of Alpha-Fetoprotein (AFP) Biomarker by Type
    • 1.3.1 Overview: Global Alpha-Fetoprotein (AFP) Biomarker Market Size by Type: 2021 Versus 2025 Versus 2032
    • 1.3.2 Global Alpha-Fetoprotein (AFP) Biomarker Consumption Value Market Share by Type in 2025
    • 1.3.3 Liver Cancer
    • 1.3.4 Testes Cancer
    • 1.3.5 Ovarian Cancer
    • 1.3.6 Others
  • 1.4 Global Alpha-Fetoprotein (AFP) Biomarker Market by Application
    • 1.4.1 Overview: Global Alpha-Fetoprotein (AFP) Biomarker Market Size by Application: 2021 Versus 2025 Versus 2032
    • 1.4.2 Hospitals
    • 1.4.3 Clinics
    • 1.4.4 Others
  • 1.5 Global Alpha-Fetoprotein (AFP) Biomarker Market Size & Forecast
  • 1.6 Global Alpha-Fetoprotein (AFP) Biomarker Market Size and Forecast by Region
    • 1.6.1 Global Alpha-Fetoprotein (AFP) Biomarker Market Size by Region: 2021 VS 2025 VS 2032
    • 1.6.2 Global Alpha-Fetoprotein (AFP) Biomarker Market Size by Region, (2021-2032)
    • 1.6.3 North America Alpha-Fetoprotein (AFP) Biomarker Market Size and Prospect (2021-2032)
    • 1.6.4 Europe Alpha-Fetoprotein (AFP) Biomarker Market Size and Prospect (2021-2032)
    • 1.6.5 Asia-Pacific Alpha-Fetoprotein (AFP) Biomarker Market Size and Prospect (2021-2032)
    • 1.6.6 South America Alpha-Fetoprotein (AFP) Biomarker Market Size and Prospect (2021-2032)
    • 1.6.7 Middle East & Africa Alpha-Fetoprotein (AFP) Biomarker Market Size and Prospect (2021-2032)

2 Company Profiles

  • 2.1 FUJIFILM
    • 2.1.1 FUJIFILM Details
    • 2.1.2 FUJIFILM Major Business
    • 2.1.3 FUJIFILM Alpha-Fetoprotein (AFP) Biomarker Product and Solutions
    • 2.1.4 FUJIFILM Alpha-Fetoprotein (AFP) Biomarker Revenue, Gross Margin and Market Share (2021-2026)
    • 2.1.5 FUJIFILM Recent Developments and Future Plans
  • 2.2 Eli Lilly and Company
    • 2.2.1 Eli Lilly and Company Details
    • 2.2.2 Eli Lilly and Company Major Business
    • 2.2.3 Eli Lilly and Company Alpha-Fetoprotein (AFP) Biomarker Product and Solutions
    • 2.2.4 Eli Lilly and Company Alpha-Fetoprotein (AFP) Biomarker Revenue, Gross Margin and Market Share (2021-2026)
    • 2.2.5 Eli Lilly and Company Recent Developments and Future Plans
  • 2.3 Fujirebio
    • 2.3.1 Fujirebio Details
    • 2.3.2 Fujirebio Major Business
    • 2.3.3 Fujirebio Alpha-Fetoprotein (AFP) Biomarker Product and Solutions
    • 2.3.4 Fujirebio Alpha-Fetoprotein (AFP) Biomarker Revenue, Gross Margin and Market Share (2021-2026)
    • 2.3.5 Fujirebio Recent Developments and Future Plans
  • 2.4 Roche Diagnostics
    • 2.4.1 Roche Diagnostics Details
    • 2.4.2 Roche Diagnostics Major Business
    • 2.4.3 Roche Diagnostics Alpha-Fetoprotein (AFP) Biomarker Product and Solutions
    • 2.4.4 Roche Diagnostics Alpha-Fetoprotein (AFP) Biomarker Revenue, Gross Margin and Market Share (2021-2026)
    • 2.4.5 Roche Diagnostics Recent Developments and Future Plans
  • 2.5 Fapon Biotech
    • 2.5.1 Fapon Biotech Details
    • 2.5.2 Fapon Biotech Major Business
    • 2.5.3 Fapon Biotech Alpha-Fetoprotein (AFP) Biomarker Product and Solutions
    • 2.5.4 Fapon Biotech Alpha-Fetoprotein (AFP) Biomarker Revenue, Gross Margin and Market Share (2021-2026)
    • 2.5.5 Fapon Biotech Recent Developments and Future Plans
  • 2.6 Labcorp
    • 2.6.1 Labcorp Details
    • 2.6.2 Labcorp Major Business
    • 2.6.3 Labcorp Alpha-Fetoprotein (AFP) Biomarker Product and Solutions
    • 2.6.4 Labcorp Alpha-Fetoprotein (AFP) Biomarker Revenue, Gross Margin and Market Share (2021-2026)
    • 2.6.5 Labcorp Recent Developments and Future Plans
  • 2.7 Thermo Fisher Scientific
    • 2.7.1 Thermo Fisher Scientific Details
    • 2.7.2 Thermo Fisher Scientific Major Business
    • 2.7.3 Thermo Fisher Scientific Alpha-Fetoprotein (AFP) Biomarker Product and Solutions
    • 2.7.4 Thermo Fisher Scientific Alpha-Fetoprotein (AFP) Biomarker Revenue, Gross Margin and Market Share (2021-2026)
    • 2.7.5 Thermo Fisher Scientific Recent Developments and Future Plans
  • 2.8 Abcam
    • 2.8.1 Abcam Details
    • 2.8.2 Abcam Major Business
    • 2.8.3 Abcam Alpha-Fetoprotein (AFP) Biomarker Product and Solutions
    • 2.8.4 Abcam Alpha-Fetoprotein (AFP) Biomarker Revenue, Gross Margin and Market Share (2021-2026)
    • 2.8.5 Abcam Recent Developments and Future Plans
  • 2.9 Bio-Techne
    • 2.9.1 Bio-Techne Details
    • 2.9.2 Bio-Techne Major Business
    • 2.9.3 Bio-Techne Alpha-Fetoprotein (AFP) Biomarker Product and Solutions
    • 2.9.4 Bio-Techne Alpha-Fetoprotein (AFP) Biomarker Revenue, Gross Margin and Market Share (2021-2026)
    • 2.9.5 Bio-Techne Recent Developments and Future Plans
  • 2.10 MyBiosource
    • 2.10.1 MyBiosource Details
    • 2.10.2 MyBiosource Major Business
    • 2.10.3 MyBiosource Alpha-Fetoprotein (AFP) Biomarker Product and Solutions
    • 2.10.4 MyBiosource Alpha-Fetoprotein (AFP) Biomarker Revenue, Gross Margin and Market Share (2021-2026)
    • 2.10.5 MyBiosource Recent Developments and Future Plans
  • 2.11 RayBiotech
    • 2.11.1 RayBiotech Details
    • 2.11.2 RayBiotech Major Business
    • 2.11.3 RayBiotech Alpha-Fetoprotein (AFP) Biomarker Product and Solutions
    • 2.11.4 RayBiotech Alpha-Fetoprotein (AFP) Biomarker Revenue, Gross Margin and Market Share (2021-2026)
    • 2.11.5 RayBiotech Recent Developments and Future Plans
  • 2.12 CUSABIO
    • 2.12.1 CUSABIO Details
    • 2.12.2 CUSABIO Major Business
    • 2.12.3 CUSABIO Alpha-Fetoprotein (AFP) Biomarker Product and Solutions
    • 2.12.4 CUSABIO Alpha-Fetoprotein (AFP) Biomarker Revenue, Gross Margin and Market Share (2021-2026)
    • 2.12.5 CUSABIO Recent Developments and Future Plans
  • 2.13 Elabscience Biotechnology
    • 2.13.1 Elabscience Biotechnology Details
    • 2.13.2 Elabscience Biotechnology Major Business
    • 2.13.3 Elabscience Biotechnology Alpha-Fetoprotein (AFP) Biomarker Product and Solutions
    • 2.13.4 Elabscience Biotechnology Alpha-Fetoprotein (AFP) Biomarker Revenue, Gross Margin and Market Share (2021-2026)
    • 2.13.5 Elabscience Biotechnology Recent Developments and Future Plans
  • 2.14 Abbexa
    • 2.14.1 Abbexa Details
    • 2.14.2 Abbexa Major Business
    • 2.14.3 Abbexa Alpha-Fetoprotein (AFP) Biomarker Product and Solutions
    • 2.14.4 Abbexa Alpha-Fetoprotein (AFP) Biomarker Revenue, Gross Margin and Market Share (2021-2026)
    • 2.14.5 Abbexa Recent Developments and Future Plans

3 Market Competition, by Players

  • 3.1 Global Alpha-Fetoprotein (AFP) Biomarker Revenue and Share by Players (2021-2026)
  • 3.2 Market Share Analysis (2025)
    • 3.2.1 Market Share of Alpha-Fetoprotein (AFP) Biomarker by Company Revenue
    • 3.2.2 Top 3 Alpha-Fetoprotein (AFP) Biomarker Players Market Share in 2025
    • 3.2.3 Top 6 Alpha-Fetoprotein (AFP) Biomarker Players Market Share in 2025
  • 3.3 Alpha-Fetoprotein (AFP) Biomarker Market: Overall Company Footprint Analysis
    • 3.3.1 Alpha-Fetoprotein (AFP) Biomarker Market: Region Footprint
    • 3.3.2 Alpha-Fetoprotein (AFP) Biomarker Market: Company Product Type Footprint
    • 3.3.3 Alpha-Fetoprotein (AFP) Biomarker Market: Company Product Application Footprint
  • 3.4 New Market Entrants and Barriers to Market Entry
  • 3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type

  • 4.1 Global Alpha-Fetoprotein (AFP) Biomarker Consumption Value and Market Share by Type (2021-2026)
  • 4.2 Global Alpha-Fetoprotein (AFP) Biomarker Market Forecast by Type (2027-2032)

5 Market Size Segment by Application

  • 5.1 Global Alpha-Fetoprotein (AFP) Biomarker Consumption Value Market Share by Application (2021-2026)
  • 5.2 Global Alpha-Fetoprotein (AFP) Biomarker Market Forecast by Application (2027-2032)

6 North America

  • 6.1 North America Alpha-Fetoprotein (AFP) Biomarker Consumption Value by Type (2021-2032)
  • 6.2 North America Alpha-Fetoprotein (AFP) Biomarker Market Size by Application (2021-2032)
  • 6.3 North America Alpha-Fetoprotein (AFP) Biomarker Market Size by Country
    • 6.3.1 North America Alpha-Fetoprotein (AFP) Biomarker Consumption Value by Country (2021-2032)
    • 6.3.2 United States Alpha-Fetoprotein (AFP) Biomarker Market Size and Forecast (2021-2032)
    • 6.3.3 Canada Alpha-Fetoprotein (AFP) Biomarker Market Size and Forecast (2021-2032)
    • 6.3.4 Mexico Alpha-Fetoprotein (AFP) Biomarker Market Size and Forecast (2021-2032)

7 Europe

  • 7.1 Europe Alpha-Fetoprotein (AFP) Biomarker Consumption Value by Type (2021-2032)
  • 7.2 Europe Alpha-Fetoprotein (AFP) Biomarker Consumption Value by Application (2021-2032)
  • 7.3 Europe Alpha-Fetoprotein (AFP) Biomarker Market Size by Country
    • 7.3.1 Europe Alpha-Fetoprotein (AFP) Biomarker Consumption Value by Country (2021-2032)
    • 7.3.2 Germany Alpha-Fetoprotein (AFP) Biomarker Market Size and Forecast (2021-2032)
    • 7.3.3 France Alpha-Fetoprotein (AFP) Biomarker Market Size and Forecast (2021-2032)
    • 7.3.4 United Kingdom Alpha-Fetoprotein (AFP) Biomarker Market Size and Forecast (2021-2032)
    • 7.3.5 Russia Alpha-Fetoprotein (AFP) Biomarker Market Size and Forecast (2021-2032)
    • 7.3.6 Italy Alpha-Fetoprotein (AFP) Biomarker Market Size and Forecast (2021-2032)

8 Asia-Pacific

  • 8.1 Asia-Pacific Alpha-Fetoprotein (AFP) Biomarker Consumption Value by Type (2021-2032)
  • 8.2 Asia-Pacific Alpha-Fetoprotein (AFP) Biomarker Consumption Value by Application (2021-2032)
  • 8.3 Asia-Pacific Alpha-Fetoprotein (AFP) Biomarker Market Size by Region
    • 8.3.1 Asia-Pacific Alpha-Fetoprotein (AFP) Biomarker Consumption Value by Region (2021-2032)
    • 8.3.2 China Alpha-Fetoprotein (AFP) Biomarker Market Size and Forecast (2021-2032)
    • 8.3.3 Japan Alpha-Fetoprotein (AFP) Biomarker Market Size and Forecast (2021-2032)
    • 8.3.4 South Korea Alpha-Fetoprotein (AFP) Biomarker Market Size and Forecast (2021-2032)
    • 8.3.5 India Alpha-Fetoprotein (AFP) Biomarker Market Size and Forecast (2021-2032)
    • 8.3.6 Southeast Asia Alpha-Fetoprotein (AFP) Biomarker Market Size and Forecast (2021-2032)
    • 8.3.7 Australia Alpha-Fetoprotein (AFP) Biomarker Market Size and Forecast (2021-2032)

9 South America

  • 9.1 South America Alpha-Fetoprotein (AFP) Biomarker Consumption Value by Type (2021-2032)
  • 9.2 South America Alpha-Fetoprotein (AFP) Biomarker Consumption Value by Application (2021-2032)
  • 9.3 South America Alpha-Fetoprotein (AFP) Biomarker Market Size by Country
    • 9.3.1 South America Alpha-Fetoprotein (AFP) Biomarker Consumption Value by Country (2021-2032)
    • 9.3.2 Brazil Alpha-Fetoprotein (AFP) Biomarker Market Size and Forecast (2021-2032)
    • 9.3.3 Argentina Alpha-Fetoprotein (AFP) Biomarker Market Size and Forecast (2021-2032)

10 Middle East & Africa

  • 10.1 Middle East & Africa Alpha-Fetoprotein (AFP) Biomarker Consumption Value by Type (2021-2032)
  • 10.2 Middle East & Africa Alpha-Fetoprotein (AFP) Biomarker Consumption Value by Application (2021-2032)
  • 10.3 Middle East & Africa Alpha-Fetoprotein (AFP) Biomarker Market Size by Country
    • 10.3.1 Middle East & Africa Alpha-Fetoprotein (AFP) Biomarker Consumption Value by Country (2021-2032)
    • 10.3.2 Turkey Alpha-Fetoprotein (AFP) Biomarker Market Size and Forecast (2021-2032)
    • 10.3.3 Saudi Arabia Alpha-Fetoprotein (AFP) Biomarker Market Size and Forecast (2021-2032)
    • 10.3.4 UAE Alpha-Fetoprotein (AFP) Biomarker Market Size and Forecast (2021-2032)

11 Market Dynamics

  • 11.1 Alpha-Fetoprotein (AFP) Biomarker Market Drivers
  • 11.2 Alpha-Fetoprotein (AFP) Biomarker Market Restraints
  • 11.3 Alpha-Fetoprotein (AFP) Biomarker Trends Analysis
  • 11.4 Porters Five Forces Analysis
    • 11.4.1 Threat of New Entrants
    • 11.4.2 Bargaining Power of Suppliers
    • 11.4.3 Bargaining Power of Buyers
    • 11.4.4 Threat of Substitutes
    • 11.4.5 Competitive Rivalry

12 Industry Chain Analysis

  • 12.1 Alpha-Fetoprotein (AFP) Biomarker Industry Chain
  • 12.2 Alpha-Fetoprotein (AFP) Biomarker Upstream Analysis
  • 12.3 Alpha-Fetoprotein (AFP) Biomarker Midstream Analysis
  • 12.4 Alpha-Fetoprotein (AFP) Biomarker Downstream Analysis

13 Research Findings and Conclusion

    14 Appendix

    • 14.1 Methodology
    • 14.2 Research Process and Data Source

    Summary:
    Get latest Market Research Reports on Alpha-Fetoprotein (AFP) Biomarker. Industry analysis & Market Report on Alpha-Fetoprotein (AFP) Biomarker is a syndicated market report, published as Global Alpha-Fetoprotein (AFP) Biomarker Market 2026 by Company, Regions, Type and Application, Forecast to 2032. It is complete Research Study and Industry Analysis of Alpha-Fetoprotein (AFP) Biomarker market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    		$3,480.00
    		$5,220.00
    		$6,960.00
    		2,690.04
    		4,035.06
    		5,380.08
    		3,239.88
    		4,859.82
    		6,479.76
    		531,361.20
    		797,041.80
    		1,062,722.40
    		293,712.00
    		440,568.00
    		587,424.00
    Credit card Logo
    Sample Question Discount Download PDF

    Related Reports

    Reason to Buy

    • Trusted By Leaders

      Top executives from leading companies purchase research reports from us. 

    • Shop With Confidence

      We assist you with all the pre-sales enquiries related to any report so that you can buy with confidence.

    • Customer Centric

      Need assistance related to your research requirements? We are just a phone call or an email away.

    • Personalized Solutions

      Our experienced research specialists are here to help you locate the right reports for your need.

    • Secure Checkout

      Shop without being worried about safety & security of your transactions.
      •

    Request for Sample of this report

    Reports and Markets

    mcafree

    Contact Us

    +1-352-353-0818 (US)

    info@reportsandmarkets.com

    Support

    EMAIL US

    Newsletter

    KEEP UP TO DATE ON ALL THE LATEST REPORTS


    maxmind_logo